vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and BANK OF HAWAII CORP (BOH). Click either name above to swap in a different company.

Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $192.3M, roughly 1.0× BANK OF HAWAII CORP). BANK OF HAWAII CORP runs the higher net margin — 29.9% vs -14.6%, a 44.4% gap on every dollar of revenue. Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 10.7%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

The Bank of Hawaii Corporation is an American regional commercial bank headquartered in Honolulu, Hawaii. It is Hawaii's second oldest bank and its largest locally owned bank in that the majority of the voting stockholders reside within the state. Bank of Hawaii has the most accounts, customers, branches, and ATMs of any financial institution in the state. The bank consists of four business segments: retail banking, commercial banking, investment services, and treasury. The bank is currently ...

AXSM vs BOH — Head-to-Head

Bigger by revenue
AXSM
AXSM
1.0× larger
AXSM
$196.0M
$192.3M
BOH
Higher net margin
BOH
BOH
44.4% more per $
BOH
29.9%
-14.6%
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
10.7%
BOH

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AXSM
AXSM
BOH
BOH
Revenue
$196.0M
$192.3M
Net Profit
$-28.6M
$57.4M
Gross Margin
Operating Margin
-13.8%
Net Margin
-14.6%
29.9%
Revenue YoY
65.0%
Net Profit YoY
61.9%
30.6%
EPS (diluted)
$-0.55
$1.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
BOH
BOH
Q1 26
$192.3M
Q4 25
$196.0M
$189.6M
Q3 25
$171.0M
$182.6M
Q2 25
$150.0M
$174.5M
Q1 25
$121.5M
$169.9M
Q4 24
$118.8M
$163.2M
Q3 24
$104.8M
$162.7M
Q2 24
$87.2M
$156.9M
Net Profit
AXSM
AXSM
BOH
BOH
Q1 26
$57.4M
Q4 25
$-28.6M
$60.9M
Q3 25
$-47.2M
$53.3M
Q2 25
$-48.0M
$47.6M
Q1 25
$-59.4M
$44.0M
Q4 24
$-74.9M
$39.2M
Q3 24
$-64.6M
$40.4M
Q2 24
$-79.3M
$34.1M
Operating Margin
AXSM
AXSM
BOH
BOH
Q1 26
Q4 25
-13.8%
40.9%
Q3 25
-27.0%
37.1%
Q2 25
-24.5%
34.6%
Q1 25
-46.9%
33.1%
Q4 24
-61.1%
31.6%
Q3 24
-59.8%
32.3%
Q2 24
-89.5%
28.9%
Net Margin
AXSM
AXSM
BOH
BOH
Q1 26
29.9%
Q4 25
-14.6%
32.1%
Q3 25
-27.6%
29.2%
Q2 25
-32.0%
27.3%
Q1 25
-48.9%
25.9%
Q4 24
-63.1%
24.0%
Q3 24
-61.7%
24.8%
Q2 24
-91.0%
21.7%
EPS (diluted)
AXSM
AXSM
BOH
BOH
Q1 26
$1.30
Q4 25
$-0.55
$1.40
Q3 25
$-0.94
$1.20
Q2 25
$-0.97
$1.06
Q1 25
$-1.22
$0.97
Q4 24
$-1.54
$0.85
Q3 24
$-1.34
$0.93
Q2 24
$-1.67
$0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
BOH
BOH
Cash + ST InvestmentsLiquidity on hand
$322.9M
$3.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$88.3M
$1.9B
Total Assets
$689.8M
$23.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
BOH
BOH
Q1 26
$3.3M
Q4 25
$322.9M
$946.5M
Q3 25
$325.3M
Q2 25
$303.0M
Q1 25
$300.9M
$935.2M
Q4 24
$315.4M
$763.6M
Q3 24
$327.3M
$1.3B
Q2 24
$315.7M
$925.3M
Total Debt
AXSM
AXSM
BOH
BOH
Q1 26
Q4 25
$558.2M
Q3 25
$558.2M
Q2 25
$558.2M
Q1 25
$558.3M
Q4 24
$558.3M
Q3 24
$558.3M
Q2 24
$560.1M
Stockholders' Equity
AXSM
AXSM
BOH
BOH
Q1 26
$1.9B
Q4 25
$88.3M
$1.9B
Q3 25
$73.7M
$1.8B
Q2 25
$73.1M
$1.7B
Q1 25
$53.2M
$1.7B
Q4 24
$57.0M
$1.7B
Q3 24
$92.9M
$1.7B
Q2 24
$102.9M
$1.6B
Total Assets
AXSM
AXSM
BOH
BOH
Q1 26
$23.9B
Q4 25
$689.8M
$24.2B
Q3 25
$669.3M
$24.0B
Q2 25
$639.8M
$23.7B
Q1 25
$596.7M
$23.9B
Q4 24
$568.5M
$23.6B
Q3 24
$561.5M
$23.8B
Q2 24
$548.2M
$23.3B
Debt / Equity
AXSM
AXSM
BOH
BOH
Q1 26
Q4 25
0.30×
Q3 25
0.31×
Q2 25
0.32×
Q1 25
0.33×
Q4 24
0.33×
Q3 24
0.34×
Q2 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
BOH
BOH
Operating Cash FlowLast quarter
$-18.7M
Free Cash FlowOCF − Capex
$-18.7M
FCF MarginFCF / Revenue
-9.6%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
BOH
BOH
Q1 26
Q4 25
$-18.7M
$218.3M
Q3 25
$1.0M
$38.5M
Q2 25
$-32.4M
$81.7M
Q1 25
$-43.4M
$18.3M
Q4 24
$-26.2M
$170.9M
Q3 24
$-18.6M
$-20.3M
Q2 24
$-30.1M
$45.7M
Free Cash Flow
AXSM
AXSM
BOH
BOH
Q1 26
Q4 25
$-18.7M
$184.3M
Q3 25
$988.0K
$29.8M
Q2 25
$-32.4M
$72.6M
Q1 25
$-43.7M
$10.2M
Q4 24
$-26.2M
$161.3M
Q3 24
$-18.7M
$-25.0M
Q2 24
$-30.2M
$40.7M
FCF Margin
AXSM
AXSM
BOH
BOH
Q1 26
Q4 25
-9.6%
97.2%
Q3 25
0.6%
16.3%
Q2 25
-21.6%
41.6%
Q1 25
-36.0%
6.0%
Q4 24
-22.1%
98.8%
Q3 24
-17.9%
-15.3%
Q2 24
-34.6%
26.0%
Capex Intensity
AXSM
AXSM
BOH
BOH
Q1 26
Q4 25
0.0%
18.0%
Q3 25
0.0%
4.7%
Q2 25
0.0%
5.2%
Q1 25
0.3%
4.8%
Q4 24
0.0%
5.9%
Q3 24
0.1%
2.8%
Q2 24
0.1%
3.2%
Cash Conversion
AXSM
AXSM
BOH
BOH
Q1 26
Q4 25
3.58×
Q3 25
0.72×
Q2 25
1.71×
Q1 25
0.42×
Q4 24
4.36×
Q3 24
-0.50×
Q2 24
1.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Segment breakdown not available.

BOH
BOH

Net Interest Income$151.0M79%
Noninterest Income$41.3M21%

Related Comparisons